Effects of Transcutaneous Electrical Nerve Stimulation over Acupoint for risk of COPD Exacerbatio
- Conditions
- chronic obstructive pulmonary disease
- Registration Number
- ITMCTR2100004798
- Lead Sponsor
- Chengdu Fifth People's Hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- Not specified
1. Comply with the diagnosis of lung distension in Chinese medicine;
2. Comply with the diagnosis of chronic obstructive pulmonary disease in western medicine, and it is in a stable phase;
3. Aged 40 to 75 years;
4. Clear consciousness, answer the questions to the point, and be able to walk independently or with support;
5. Be informed and sign the consent form;
6. Have not experienced transcutaneous electrical acupoint stimulation in the past.
1. Patients with severe heart, brain, blood vessels, liver and kidney dysfunction, cancer patients,and severe mental disorders;
2. Pregnant and lactating women;
3. Have an acute exacerbation of COPD in three months;
4. Have attended any other studies in six months;
5. Allergic to the sticking agent.
Study & Design
- Study Type
- Interventional study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method hospital admissions;frequency of exacerbations;
- Secondary Outcome Measures
Name Time Method lung function;6 minutes walking distance;